Recognify Life Sciences Provides Update on Phase 2b Trial of Inidascamine in Patients with Schizophrenia Read More » July 28, 2025
Trusted by Leading Cancer Centers to Solve Oncology’s Information Overload, Triomics Raises $22 million to Accelerate Adoption
Coral Raises $12.5m to Automate Healthcare’s Back Office by Working With, Not Against, the Fax Machine